Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 563 entries
Sorted by: Best Match Show Resources per page
Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Evidence-based complementary and alternative medicine : eCAM

Bhattacharjee N, Pathak S, Khuda-Bukhsh AR.
PMID: 18955221
Evid Based Complement Alternat Med. 2009 Mar;6(1):65-75. doi: 10.1093/ecam/nem067. Epub 2007 Jun 19.

To examine if a potentized homeopathic drug, Natrum Sulphuricum 200 (Nat Sulph-200) has protective potentials against hepatocarcinogenesis, liver tumors were induced in mice through chronic feeding of P-dimethylaminoazobenzene (p-DAB; initiator of hepatocarcinogenesis) and phenobarbital (PB; promoter). Mice were divided...

Cite
Bhattacharjee N, Pathak S, Khuda-Bukhsh AR. Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200. Evid Based Complement Alternat Med. 2007;6(1):65-75doi: 10.1093/ecam/nem067.
Bhattacharjee, N., Pathak, S., & Khuda-Bukhsh, A. R. (2009). Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200. Evidence-based complementary and alternative medicine : eCAM, 6(1), 65-75. https://doi.org/10.1093/ecam/nem067
Bhattacharjee, Nandini, et al. "Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200." Evidence-based complementary and alternative medicine : eCAM vol. 6,1 (2009): 65-75. doi: https://doi.org/10.1093/ecam/nem067
Bhattacharjee N, Pathak S, Khuda-Bukhsh AR. Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200. Evid Based Complement Alternat Med. 2009 Mar;6(1):65-75. doi: 10.1093/ecam/nem067. Epub 2007 Jun 19. PMID: 18955221; PMCID: PMC2644277.
Copy Download .nbib Format: NLM
Sensitive analysis of two barbiturates in human urine by capillary electrophoresis with sample stacking induced by moving reaction boundary.

Analytica chimica acta

Wang QL, Fan LY, Zhang W, Cao CX.
PMID: 17723774
Anal Chim Acta. 2006 Nov 24;580(2):200-5. doi: 10.1016/j.aca.2006.07.073. Epub 2006 Aug 04.

An on-line stacking method based on moving reaction boundary (MRB) was developed for the sensitive determination of barbital and phenobarbital in human urine via capillary electrophoresis (CE). The optimized conditions for the method are: 60 mmol L(-1) pH 11.0...

Cite
Wang QL, Fan LY, Zhang W, et al. Sensitive analysis of two barbiturates in human urine by capillary electrophoresis with sample stacking induced by moving reaction boundary. Anal Chim Acta. 2006;580(2):200-5doi: 10.1016/j.aca.2006.07.073.
Wang, Q. L., Fan, L. Y., Zhang, W., & Cao, C. X. (2006). Sensitive analysis of two barbiturates in human urine by capillary electrophoresis with sample stacking induced by moving reaction boundary. Analytica chimica acta, 580(2), 200-5. https://doi.org/10.1016/j.aca.2006.07.073
Wang, Qiu-Ling, et al. "Sensitive analysis of two barbiturates in human urine by capillary electrophoresis with sample stacking induced by moving reaction boundary." Analytica chimica acta vol. 580,2 (2006): 200-5. doi: https://doi.org/10.1016/j.aca.2006.07.073
Wang QL, Fan LY, Zhang W, Cao CX. Sensitive analysis of two barbiturates in human urine by capillary electrophoresis with sample stacking induced by moving reaction boundary. Anal Chim Acta. 2006 Nov 24;580(2):200-5. doi: 10.1016/j.aca.2006.07.073. Epub 2006 Aug 04. PMID: 17723774.
Copy Download .nbib Format: NLM
Phenobarbital-induced bullous lesions in a non-comatose patient.

Psychiatry (Edgmont (Pa. : Township))

Keng M, Lagos M, Liepman MR, Trever K.
PMID: 20877558
Psychiatry (Edgmont). 2006 Dec;3(12):65-9.

The occurrence of dermatologic bullous lesions is well documented after barbiturate-induced intoxication. However, this rare clinicopathological entity is only reported in the setting of a coma or lethal toxicity. This case report presents a case of a noncomatose, nonimmobilized...

Cite
Keng M, Lagos M, Liepman MR, et al. Phenobarbital-induced bullous lesions in a non-comatose patient. Psychiatry (Edgmont). 2006;3(12):65-9
Keng, M., Lagos, M., Liepman, M. R., & Trever, K. (2006). Phenobarbital-induced bullous lesions in a non-comatose patient. Psychiatry (Edgmont (Pa. : Township)), 3(12), 65-9.
Keng, Michael, et al. "Phenobarbital-induced bullous lesions in a non-comatose patient." Psychiatry (Edgmont (Pa. : Township)) vol. 3,12 (2006): 65-9.
Keng M, Lagos M, Liepman MR, Trever K. Phenobarbital-induced bullous lesions in a non-comatose patient. Psychiatry (Edgmont). 2006 Dec;3(12):65-9. PMID: 20877558; PMCID: PMC2945899.
Copy Download .nbib Format: NLM
Treatment considerations during pregnancy for women with epilepsy.

Women's health (London, England)

Harden CL, Nadiminti L.
PMID: 19803913
Womens Health (Lond). 2006 May;2(3):415-23. doi: 10.2217/17455057.2.3.415.

Women with epilepsy have many special considerations; one of the most important of these is the risk and management of pregnancy. Both recurrent seizures during pregnancy and antiepileptic medications may have adverse maternal-fetal outcomes. Multiple registries of pregnancy outcomes...

Cite
Harden CL, Nadiminti L. Treatment considerations during pregnancy for women with epilepsy. Womens Health (Lond). 2006;2(3):415-23doi: 10.2217/17455057.2.3.415.
Harden, C. L., & Nadiminti, L. (2006). Treatment considerations during pregnancy for women with epilepsy. Women's health (London, England), 2(3), 415-23. https://doi.org/10.2217/17455057.2.3.415
Harden, Cynthia L, and Nadiminti, Lakshmi. "Treatment considerations during pregnancy for women with epilepsy." Women's health (London, England) vol. 2,3 (2006): 415-23. doi: https://doi.org/10.2217/17455057.2.3.415
Harden CL, Nadiminti L. Treatment considerations during pregnancy for women with epilepsy. Womens Health (Lond). 2006 May;2(3):415-23. doi: 10.2217/17455057.2.3.415. PMID: 19803913.
Copy Download .nbib Format: NLM
Use of clinical and paraclinical data to diagnose appendicitis in a patient with abdominal epilepsy.

Canadian family physician Medecin de famille canadien

Lloyd S, Sharma A.
PMID: 21248880
Can Fam Physician. 1989 Feb;35:235-9.

We report a case of acute appendicitis in a 36-year-old patient with recurrent abdominal pain diagnosed seven years previously as abdominal epilepsy. Prior to his reported presentation, he successfully managed his pain at home by self-administration of phenobarbital, but...

Cite
Lloyd S, Sharma A. Use of clinical and paraclinical data to diagnose appendicitis in a patient with abdominal epilepsy. Can Fam Physician. 1989;35:235-9
Lloyd, S., & Sharma, A. (1989). Use of clinical and paraclinical data to diagnose appendicitis in a patient with abdominal epilepsy. Canadian family physician Medecin de famille canadien, 35235-9.
Lloyd, S, and Sharma, A. "Use of clinical and paraclinical data to diagnose appendicitis in a patient with abdominal epilepsy." Canadian family physician Medecin de famille canadien vol. 35 (1989): 235-9.
Lloyd S, Sharma A. Use of clinical and paraclinical data to diagnose appendicitis in a patient with abdominal epilepsy. Can Fam Physician. 1989 Feb;35:235-9. PMID: 21248880; PMCID: PMC2280258.
Copy Download .nbib Format: NLM
Evaluation of mutagenicity of mebudipine, a new calcium channel blocker.

Iranian journal of pharmaceutical research : IJPR

Gholami S, Soleimani F, Hoseini Shirazi F, Touhidpour M, Mahmoudian M.
PMID: 24363706
Iran J Pharm Res. 2010;9(1):49-53.

Mebudipine is a new dihydropyridine calcium channel blocker, synthesized in our laboratory, for treatment of hypertension. It has shown a better efficacy than other drugs in this group. For assessing the risks of this drug, certain safety tests in...

Cite
Gholami S, Soleimani F, Hoseini Shirazi F, et al. Evaluation of mutagenicity of mebudipine, a new calcium channel blocker. Iran J Pharm Res. 2010;9(1):49-53
Gholami, S., Soleimani, F., Hoseini Shirazi, F., Touhidpour, M., & Mahmoudian, M. (2010). Evaluation of mutagenicity of mebudipine, a new calcium channel blocker. Iranian journal of pharmaceutical research : IJPR, 9(1), 49-53.
Gholami, Saeid, et al. "Evaluation of mutagenicity of mebudipine, a new calcium channel blocker." Iranian journal of pharmaceutical research : IJPR vol. 9,1 (2010): 49-53.
Gholami S, Soleimani F, Hoseini Shirazi F, Touhidpour M, Mahmoudian M. Evaluation of mutagenicity of mebudipine, a new calcium channel blocker. Iran J Pharm Res. 2010;9(1):49-53. PMID: 24363706; PMCID: PMC3869550.
Copy Download .nbib Format: NLM
Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine.

The World Allergy Organization journal

Aouam K, Fredj Nadia B, Amel C, Naceur B.
PMID: 23282653
World Allergy Organ J. 2010 Jul;3(7):220-2. doi: 10.1097/WOX.0b013e3181eab930.

The anticonvulsant hypersensitivity syndrome, also known as drug rash eosinophilia and systemic symptoms (DRESS), is a rare but severe form of adverse cutaneous reaction. Several aromatic anticonvulsant drugs, such as carbamazepine (CBZ), phenytoin, or phenobarbital have been frequently associated...

Cite
Aouam K, Fredj Nadia B, Amel C, et al. Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine. World Allergy Organ J. 2010;3(7):220-2doi: 10.1097/WOX.0b013e3181eab930.
Aouam, K., Fredj Nadia, B., Amel, C., & Naceur, B. (2010). Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine. The World Allergy Organization journal, 3(7), 220-2. https://doi.org/10.1097/WOX.0b013e3181eab930
Aouam, Karim, et al. "Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine." The World Allergy Organization journal vol. 3,7 (2010): 220-2. doi: https://doi.org/10.1097/WOX.0b013e3181eab930
Aouam K, Fredj Nadia B, Amel C, Naceur B. Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine. World Allergy Organ J. 2010 Jul;3(7):220-2. doi: 10.1097/WOX.0b013e3181eab930. PMID: 23282653; PMCID: PMC3651104.
Copy Download .nbib Format: NLM
Interpretation of controversial teratogenic findings of drugs such as phenobarbital.

ISRN obstetrics and gynecology

Czeizel AE, Dudás I, Bánhidy F.
PMID: 21904684
ISRN Obstet Gynecol. 2011;2011:719675. doi: 10.5402/2011/719675. Epub 2011 Sep 04.

Objective. To check the debated association between phenobarbital treatment during pregnancy and risk for congenital abnormalities (CAs) in their children. Study Design. It is a comparison of phenobarbital treatment in the mothers of cases with CA and matched controls...

Cite
Czeizel AE, Dudás I, Bánhidy F. Interpretation of controversial teratogenic findings of drugs such as phenobarbital. ISRN Obstet Gynecol. 2011;2011:719675doi: 10.5402/2011/719675.
Czeizel, A. E., Dudás, I., & Bánhidy, F. (2011). Interpretation of controversial teratogenic findings of drugs such as phenobarbital. ISRN obstetrics and gynecology, 2011719675. https://doi.org/10.5402/2011/719675
Czeizel, Andrew E, et al. "Interpretation of controversial teratogenic findings of drugs such as phenobarbital." ISRN obstetrics and gynecology vol. 2011 (2011): 719675. doi: https://doi.org/10.5402/2011/719675
Czeizel AE, Dudás I, Bánhidy F. Interpretation of controversial teratogenic findings of drugs such as phenobarbital. ISRN Obstet Gynecol. 2011;2011:719675. doi: 10.5402/2011/719675. Epub 2011 Sep 04. PMID: 21904684; PMCID: PMC3166760.
Copy Download .nbib Format: NLM
Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient.

Pediatric neurology

Russell KE, Mulligan SR, Mallory LA.
PMID: 22759694
Pediatr Neurol. 2012 Aug;47(2):141-3. doi: 10.1016/j.pediatrneurol.2012.04.018.

Although a diagnosis of pyridoxine-dependent seizures may commonly be delayed, this case involves an extremely late diagnosis with associated morbidity. Our patient received pyridoxine during the neonatal period, in conjunction with other antiepileptic drugs that masked its effect. This...

Cite
Russell KE, Mulligan SR, Mallory LA. Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient. Pediatr Neurol. 2012;47(2):141-3doi: 10.1016/j.pediatrneurol.2012.04.018.
Russell, K. E., Mulligan, S. R., & Mallory, L. A. (2012). Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient. Pediatric neurology, 47(2), 141-3. https://doi.org/10.1016/j.pediatrneurol.2012.04.018
Russell, Kate E, et al. "Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient." Pediatric neurology vol. 47,2 (2012): 141-3. doi: https://doi.org/10.1016/j.pediatrneurol.2012.04.018
Russell KE, Mulligan SR, Mallory LA. Diagnosis of pyridoxine-dependent seizures in a nineteen-year-old patient. Pediatr Neurol. 2012 Aug;47(2):141-3. doi: 10.1016/j.pediatrneurol.2012.04.018. PMID: 22759694.
Copy Download .nbib Format: NLM
Structure-dependent induction of CYP2B1/2 by 3-methylsulfonyl metabolites of polychlorinated biphenyl congeners in rats.

Environmental toxicology and pharmacology

Kato Y, Haraguchi K, Tomiyasu K, Hiroyuki Saito, Isogai M, Masuda Y, Kimura R.
PMID: 21781771
Environ Toxicol Pharmacol. 1997 Jun 06;3(2):137-44. doi: 10.1016/s1382-6689(97)00150-6.

The effects of eleven 3-methylsulfonyl (3-MeSO(2))-metabolites of polychlorinated biphenyl (PCB) congeners (which were reported to remain in Swedish mother's milk and Japanese Yusho patient's tissues) and their two structurally similar 3-MeSO(2)-PCBs on the hepatic drug-metabolizing enzyme activities were compared...

Cite
Kato Y, Haraguchi K, Tomiyasu K, et al. Structure-dependent induction of CYP2B1/2 by 3-methylsulfonyl metabolites of polychlorinated biphenyl congeners in rats. Environ Toxicol Pharmacol. 1997;3(2):137-44doi: 10.1016/s1382-6689(97)00150-6.
Kato, Y., Haraguchi, K., Tomiyasu, K., Hiroyuki Saito, Isogai, M., Masuda, Y., & Kimura, R. (1997). Structure-dependent induction of CYP2B1/2 by 3-methylsulfonyl metabolites of polychlorinated biphenyl congeners in rats. Environmental toxicology and pharmacology, 3(2), 137-44. https://doi.org/10.1016/s1382-6689(97)00150-6
Kato, Y, et al. "Structure-dependent induction of CYP2B1/2 by 3-methylsulfonyl metabolites of polychlorinated biphenyl congeners in rats." Environmental toxicology and pharmacology vol. 3,2 (1997): 137-44. doi: https://doi.org/10.1016/s1382-6689(97)00150-6
Kato Y, Haraguchi K, Tomiyasu K, Hiroyuki Saito, Isogai M, Masuda Y, Kimura R. Structure-dependent induction of CYP2B1/2 by 3-methylsulfonyl metabolites of polychlorinated biphenyl congeners in rats. Environ Toxicol Pharmacol. 1997 Jun 06;3(2):137-44. doi: 10.1016/s1382-6689(97)00150-6. PMID: 21781771.
Copy Download .nbib Format: NLM
Effects of anticonvulsant therapy on recovery and rehabilitation.

NeuroRehabilitation

Lee GP, Meador KJ.
PMID: 24525542
NeuroRehabilitation. 1995;5(3):281-8. doi: 10.3233/NRE-1995-5310.

Antiepileptic drugs (AEDs) are used in rehabilitation patients with injury to the nervous system for control of clinical seizures, prophylaxis against the development of a seizure disorder, and treatment of secondary mania. Although most AEDs can produce mild cognitive...

Cite
Lee GP, Meador KJ. Effects of anticonvulsant therapy on recovery and rehabilitation. NeuroRehabilitation. 1995;5(3):281-8doi: 10.3233/NRE-1995-5310.
Lee, G. P., & Meador, K. J. (1995). Effects of anticonvulsant therapy on recovery and rehabilitation. NeuroRehabilitation, 5(3), 281-8. https://doi.org/10.3233/NRE-1995-5310
Lee, G P, and Meador, K J. "Effects of anticonvulsant therapy on recovery and rehabilitation." NeuroRehabilitation vol. 5,3 (1995): 281-8. doi: https://doi.org/10.3233/NRE-1995-5310
Lee GP, Meador KJ. Effects of anticonvulsant therapy on recovery and rehabilitation. NeuroRehabilitation. 1995;5(3):281-8. doi: 10.3233/NRE-1995-5310. PMID: 24525542.
Copy Download .nbib Format: NLM
Occipital status epilepticus: an unusual case of post-traumatic blindness.

NeuroRehabilitation

Black KL, Obayan A, Zafonte RD, Mann NR, Hammond F, Wood D.
PMID: 24525892
NeuroRehabilitation. 1996;7(3):219-21. doi: 10.3233/NRE-1996-7308.

Post-traumatic seizures can be a cause of multiple clinical and behavioral abnormalities. We present an unusual case of post-traumatic epilepsy resulting in blindness. The patient was a 35-year-old female with a past history of toxemia of pregnancy who was...

Cite
Black KL, Obayan A, Zafonte RD, et al. Occipital status epilepticus: an unusual case of post-traumatic blindness. NeuroRehabilitation. 1996;7(3):219-21doi: 10.3233/NRE-1996-7308.
Black, K. L., Obayan, A., Zafonte, R. D., Mann, N. R., Hammond, F., & Wood, D. (1996). Occipital status epilepticus: an unusual case of post-traumatic blindness. NeuroRehabilitation, 7(3), 219-21. https://doi.org/10.3233/NRE-1996-7308
Black, K L, et al. "Occipital status epilepticus: an unusual case of post-traumatic blindness." NeuroRehabilitation vol. 7,3 (1996): 219-21. doi: https://doi.org/10.3233/NRE-1996-7308
Black KL, Obayan A, Zafonte RD, Mann NR, Hammond F, Wood D. Occipital status epilepticus: an unusual case of post-traumatic blindness. NeuroRehabilitation. 1996;7(3):219-21. doi: 10.3233/NRE-1996-7308. PMID: 24525892.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 563 entries